SITC Archive Library

On July 16, 2021, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from ESMO Immuno-Oncology Virtual Congress 2020. The recorded webinar and presentation slides are available below.

Indicates this content is not available on-demand. 

Webinar Faculty:

• Moderator: Paolo A. Ascierto, MD – Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale'
• Presenters:
  • Sunandana Chandra, MD, MS – Northwestern University
  • Julia Katharina Schwarze, MD, MSc – University Hospital Brussels

Joseph Sacco, MBChB, MSc, MRCP, PhD – The Clatterbridge Cancer Centre

Featured Presentations:

• A Phase (ph) 2, Multi-Center Study of the Safety and Efficacy of tebentafusp (tebe) (IMCgp100) in Patients (pts) with Metastatic Uveal Melanoma (mUM) - Presenter: Joseph Sacco, MBChB, MSc, MRCP, PhD
• A phase I clinical trial on intratumoral (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma - Julia Katharina Schwarze, MD, MSc
• Additional clinical abstracts of interest from ESMO Immuno-Oncology Congress 2020 will be presented by Sunandana Chandra, MD, MS

Please note that the on-demand webinar is not available for continuing education credits.